philip j. barter, et al. circulation 2011;124:555-562

Philip J. Barter, et al. Circulation 2011;124:555-562

Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part I

Philip J. Barter, et al. Circulation 2011;124:555-562

Baseline Characteristics of Randomized Subjects With Diabetes Mellitus – Part II

Philip J. Barter, et al. Circulation 2011;124:555-562

Effects of Treatment With Atorvastatin vs the Combination of Atorvastatin and Torcetrapib on Plasma Glucose, Hemoglobin A1c, Serum Insulin,

HOMA-IR, and HDL Cholesterol for the Subgroup of Diabetic Subjects

Philip J. Barter, et al. Circulation 2011;124:555-562

Between-Treatment Comparison of Changes in Glucose, Insulin, Hemoglobin A1c, and HOMA-IR Adjusted for Change in HDL Cholesterol - I

Philip J. Barter, et al. Circulation 2011;124:555-562

Philip J. Barter, et al. Circulation 2011;124:555-562

Between-Treatment Comparison of Changes in Glucose, Insulin, Hemoglobin A1c, and HOMA-IR Adjusted for Change in HDL Cholesterol - II

Effects of Treatment With Atorvastatin vs the Combination of Atorvastatin and Torcetrapib on Plasma Glucose, Hemoglobin A1c, Serum Insulin,

HOMA-IR, and HDL Cholesterol for the Subgroup of Nondiabetic Subjects

Philip J. Barter, et al. Circulation 2011;124:555-562

CLINICAL PERSPECTIVE

Philip J. Barter, et al. Circulation 2011;124:555-562